The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)

Head and Face Medicine

Volumn 6, Issue 1, 2010, Pages

  Jung, Susanne ^a   Wermker, Kai ^a   Poetschik, Harald ^b   Ziebura, Thomas ^a   Kleinheinz, Johannes ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Private practice   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; HUMAN; HYPERBARIC OXYGEN; MALE; MIDDLE AGED; PERCEPTION DEAFNESS; TINNITUS;

ADOLESCENT; ADULT; AGED; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEARING LOSS, SENSORINEURAL; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED; TINNITUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650365796     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-6-29     Document Type: Article

References (29)

1. Jacobson JH, Morsch JCH, Rendell-Baker L. The historical perspective of hyperbaric therapy. Ann N Y Acad Sci 1965, 117:651-670.
2. Camporesi RM. Hyperbaric oxygen therapy: A Committee Report. Undersea and Hyperbaric Medical Society 1996, Kensington MD USA.
3. Kindwall EP, Whelan HT. Hyperbaric medicine practice 2008, Flagstaff: Best Publishing Company.
4. Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1979, 135:561-7.
5. Siddiqui A, Galiano RD, Connors D, Gruskin E, Wu L, Mustoe TA. Differential effects of oxygen on human dermal fibroblasts: acute versus chronic hypoxia. Wound Repair Regen 1996, 4:211-8. 10.1046/j.1524-475X.1996.40207.x, 17177815.
6. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Rev 1997, 18:4-25.
7. Inui K, Maeda M, Sano A, Fujioka K, Yutani Y, Sakawa A, Yamano Y, Kato Y, Koike T. Local application of basic fibroblast growth factor minipellet induces the healing of segmental bony defects in rabbits. Calcif Tissue Int 1998, 63:490-5. 10.1007/s002239900563, 9817943.
8. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol 1988, 130:393-400. 1880518, 3277442.
9. Robson MC, Phillips LG, Lawrence WT, Bishop JB, Youngerman JS, Hayward PG, Broemeling LD, Heggers JP. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 1992, 216:401-6. 10.1097/00000658-199210000-00002, 1242638, 1417189.
10. Brattström D, Bergqvist M, Larsson A, Holmertz J, Hesselius P, Rosenberg L, Brodin O, Wagenius G. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. Anticancer Res 1998, 18:1123-7.
11. Dellacono FR, Spiro J, Eisma R, Kreutzer D. Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am J Surg 1997, 174:540-4. 10.1016/S0002-9610(97)00169-4, 9374233.
12. Hayward P, Hokanson J, Heggers J, Fiddes J, Klingbeil C, Goeger M, Robson M. Fibroblast growth factor reserves the bacterial retardation of wound contraction. Am J Surg 1992, 163:288-93. 10.1016/0002-9610(92)90004-B, 1539760.
13. Mattei MG, Borg JP, Rosnet O, Marmé D, Birnbaum D. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics 1996, 32:168-9. 10.1006/geno.1996.0098, 8786112.
14. Drake CJ, Little CD. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci USA 1995, 92:7657-61. 10.1073/pnas.92.17.7657, 41204, 7543999.
15. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989, 246:1309-12. 10.1126/science.2479987, 2479987.
16. Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994, 4:207-18. 10.1111/j.1750-3639.1994.tb00835.x, 7524960.
17. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993, 12:303-24. 10.1007/BF00665960, 8281615.
18. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66-70. 10.1038/376066a0, 7596436.
19. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994, 269:26988-95.
20. Dietz A, Rudat V, Vanselow B, Conradt C, Möhler T. [Predictive value of serum levels of basic fibroblast growth factor, vascular endothelial growth factor and matrix metalloproteinase-2 in advanced carcinomas of the head and neck]. HNO 1999, 47:695-701. 10.1007/s001060050447, 10506495.
21. Kang TS, Gorti GK, Quan SY, Ho M, Koch RJ. Effect of hyperbaric oxygen on the growth factor profile of fibroblasts. Arch Facial Plast Surg 2004, 6:31-5. 10.1001/archfaci.6.1.31, 14732642.
22. Ladoux A, Frelin C. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem Biophys Res Commun 1993, 195:1005-10. 10.1006/bbrc.1993.2144, 8373380.
23. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31. 10.1038/nm0195-27, 7584949.
24. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995, 92:II365-71.
25. Salven P, Mänpää H, Orpana A, Alitalo K, Joensuu H. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 1997, 3:647-51.
26. Dirix LY, Vermeulen PB, Pawinski A, Prové A, Benoy I, De Pooter C, Martin M, Van Oosterom AT. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 1997, 76:238-43. 2223937, 9231925.
27. Kondo S, Asano M, Suzuki H. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 1993, 194:1234-41. 10.1006/bbrc.1993.1955, 7688963.
28. Salven P, Heikkilä P, Anttonen A, Kajanti M, Joensuu H. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 1997, (10):1128-33.
29. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8. 10.1056/NEJM199101033240101, 1701519.